Marián Hajdúch explains how a potential cancer drug is developed, from an initial laboratory compound to an approved medicine. It outlines the key stages of the process, including basic research, preclinical testing, and multi-phase clinical trials in patients. The segment also highlights how long and demanding drug development is, the importance of safety and efficacy testing, and the role of regulatory authorities before a drug can be used in clinical practice.
Watch the whole interview on ceskatelevize.cz
